Experienced in Multiple Sclerosis (MS)

Ana M. Silva

Porto, PT 
Experienced in Multiple Sclerosis (MS)
Porto, PT 
OverviewLocationsClinical Research

Overview

Ana Silva practices in Porto, Portugal. Ms. Silva is rated as an Experienced expert by MediFind in the treatment of Multiple Sclerosis (MS). Her top areas of expertise are Multiple Sclerosis (MS), Transverse Myelitis, Neuromyelitis Optica, Thymectomy, and Laryngectomy.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 10 articles and participated in 1 clinical trial in the study of Multiple Sclerosis (MS).

Gender
Female

Locations

Porto, 4099001, Portugal
Other Locations
Santo Antonio De Felheiros, 4099001, Portugal
Gandra, Portugal

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients With Relapsing Remitting Multiple Sclerosis (MS) Transitioning From Current Subcutaneous Interferon Therapy to Peginterferon Beta 1a (PLEGRIDY™)
Open-label, Randomized, 2-arm, Active Comparator Study to Evaluate Safety and Tolerability in Portuguese Patients With Relapsing Remitting Multiple Sclerosis (MS) Transitioning From Current Subcutaneous Interferon Therapy to Peginterferon Beta 1a (PLEGRIDY™)
Enrollment Status: Completed
Publish Date: November 25, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
A Phase 1, Open-label, Dose Escalation Study of Intravenous PRX004 in Subjects With Amyloid Transthyretin (ATTR) Amyloidosis
Enrollment Status: Terminated
Publish Date: August 20, 2020
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

24 Total Publications

Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers.
Characterization of Anti-GAD65-Associated Neurological Syndromes: Clinical Features and Antibody Titers.
Journal: NeuroSci
Published: May 01, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Silva's expertise for a condition
ConditionClose
        View All 15 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile